Bernhard's main focus lies in the drafting and handling of patents in the areas of electric engineering, software inventions as well as devices for biotechnology and optics. Furthermore he possesses great experience in opposition cases and IP litigation cases as well as trade mark protection.
Bernhard studied Applied Physics at the Technical University of Munich. He has been in the IP business since 1990. He was accredited as a German Patent Attorney in 1994 and in the same year also qualified as a European Patent Attorney.
He has made his name as a specialist legal author with, amongst others, with the article “Patent situation in the field of DNA chip technology in Europe” (which appeared in no. 12/2000 of medgen, the newsletter of the German Association for Human Genetics) and the article “Is the core theory once again topical?” (which appeared in the Transactions of German Patent Attorneys in December 2003), dealing with German case law in respect of software inventions. This article was cited by the Enlarged Board of Appeal in the up to now only decision (G 03/08) relating to computer implemented inventions. He regularly gives lectures on different topics in IP law.
Bernhard is a member of the Licensing Executive Society (LES) and the European Patent Experts Exchange (EuPEX).
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.